---
figid: PMC5340181__oncotarget-07-75407-g007
figlink: /pmc/articles/PMC5340181/figure/F7/
number: F7
caption: A combination therapy of gemcitabine and a SOD mimetic inhibits IDO, GCN2,
  and mTOR pathway activation in IDO-expressing MDSCs and LLCs. This reverses immune
  suppression, reduces anti-tumor T cell exhaustion, and rescues mTOR activation in
  CD8+ T cells enabling their expansion and reprogramming towards a glycolytic state.
  Phosphorylation of S6 in CD8+ T cells licenses IFN-γ production necessary to elicit
  cytotoxic effects, diminishing tumor burden and restoring anti-tumor immunity.
pmcid: PMC5340181
papertitle: Indoleamine 2,3-dioxygenase regulates anti-tumor immunity in lung cancer
  by metabolic reprogramming of immune cells in the tumor microenvironment.
reftext: Cara C. Schafer, et al. Oncotarget. 2016 Nov 15;7(46):75407-75424.
pmc_ranked_result_index: '6020'
pathway_score: 0.830707
filename: oncotarget-07-75407-g007.jpg
figtitle: Indoleamine 2,3-dioxygenase regulates anti-tumor immunity in lung cancer
  by metabolic reprogramming of immune cells in the tumor microenvironment
year: '2016'
organisms: Homo sapiens
ndex: 18dce39e-df23-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5340181__oncotarget-07-75407-g007.html
  '@type': Dataset
  description: A combination therapy of gemcitabine and a SOD mimetic inhibits IDO,
    GCN2, and mTOR pathway activation in IDO-expressing MDSCs and LLCs. This reverses
    immune suppression, reduces anti-tumor T cell exhaustion, and rescues mTOR activation
    in CD8+ T cells enabling their expansion and reprogramming towards a glycolytic
    state. Phosphorylation of S6 in CD8+ T cells licenses IFN-γ production necessary
    to elicit cytotoxic effects, diminishing tumor burden and restoring anti-tumor
    immunity.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TNF
  - HAVCR2
  - MTOR
  - SOD1
  - SOD3
  - RORC
  - IL2
  - SOD2
  - CD8B
  - EIF2AK4
  - CTLA4
  - CD8A
  - IDO1
  - LAG3
genes:
- word: TNF-a
  symbol: TNF-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: +TIM-3
  symbol: Tim-3
  source: hgnc_alias_symbol
  hgnc_symbol: HAVCR2
  entrez: '84868'
- word: TIM-3
  symbol: Tim-3
  source: hgnc_alias_symbol
  hgnc_symbol: HAVCR2
  entrez: '84868'
- word: ↑MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: SOD
  symbol: SOD
  source: bioentities_symbol
  hgnc_symbol: SOD1
  entrez: '6647'
- word: SOD
  symbol: SOD
  source: bioentities_symbol
  hgnc_symbol: SOD3
  entrez: '6649'
- word: TOR
  symbol: TOR
  source: hgnc_alias_symbol
  hgnc_symbol: RORC
  entrez: '6097'
- word: IL-2
  symbol: IL-2
  source: hgnc_alias_symbol
  hgnc_symbol: IL2
  entrez: '3558'
- word: SOD
  symbol: SOD
  source: bioentities_symbol
  hgnc_symbol: SOD2
  entrez: '6648'
- word: CD8*
  symbol: CD8
  source: bioentities_symbol
  hgnc_symbol: CD8B
  entrez: '926'
- word: GCN2
  symbol: GCN2
  source: hgnc_alias_symbol
  hgnc_symbol: EIF2AK4
  entrez: '440275'
- word: CTLA-4
  symbol: CTLA4
  source: hgnc_symbol
  hgnc_symbol: CTLA4
  entrez: '1493'
- word: CD8*
  symbol: CD8
  source: bioentities_symbol
  hgnc_symbol: CD8A
  entrez: '925'
- word: ↑IDO
  symbol: IDO
  source: hgnc_prev_symbol
  hgnc_symbol: IDO1
  entrez: '3620'
- word: +LAG-3
  symbol: LAG3
  source: hgnc_symbol
  hgnc_symbol: LAG3
  entrez: '3902'
- word: ↑IL-2
  symbol: IL2
  source: hgnc_symbol
  hgnc_symbol: IL2
  entrez: '3558'
chemicals: []
diseases: []
figid_alias: PMC5340181__F7
redirect_from: /figures/PMC5340181__F7
figtype: Figure
---
